Connection

John Wrangle to Antineoplastic Agents

Back to Details
This is a "connection" page, showing publications John Wrangle has written about Antineoplastic Agents.
John Wrangle
Connection Strength
0.106
Antineoplastic Agents
  1. First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer. N Engl J Med. 2017 06 22; 376(25):2415-2426.
    View in: PubMed
    Score: 0.085
  2. Murine Th17 cells utilize IL-2 receptor gamma chain cytokines but are resistant to cytokine withdrawal-induced apoptosis. Cancer Immunol Immunother. 2017 Jun; 66(6):737-751.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.